Plymouth Clubs’ Tournaments Raise $60K For Type 1 Diabetes Research 

Filed Under: Health Care, Non Profit News

Thanks to 150 participants swinging away in tennis and golf tournaments held Sept. 15 in Plymouth, Type One raised more than $60,000 in support of Type 1 diabetes research and to assist those living with the disease.

Hingham-based Type One has made an impact toward their mission of funding research to cure type 1 diabetes (T1D) by supporting the Faustman Lab at Massachusetts General Hospital (MGH), while also helping provide scholarships to local children with Type 1 diabetes to attend Type 1 diabetes camp, and providing qualifying recipients with assistance for diabetes management and treatment.

Type One Golf Tennis events. 2021 2
From left, Nathan Sunnerberg; Tyson Sunnerberg, co-founder of Type One; Dr. Denise Faustman; Paul Foti, co-founder of Type One and Elyse Sunnerberg.

Type One, a 501(c)(3) nonprofit organization held their first “Serving For The Cure!” tennis tournament on the indoor tennis courts at the Village Racquet & Fitness Club in Plymouth. The tournament was held in tandem with the organization’s inaugural “Par For The Cure! Golf Tourney” held the same day at Crosswinds Golf Club, also in Plymouth. Both events sold out.

Following the tournaments, tennis players and golfers gathered for cocktails, hors d’oeuvres, raffle, silent auction and live entertainment with Ward Hayden of Ward Hayden & The Outliers acoustic live performance at Crosswinds Golf Club.

During the reception, special guest Dr. Denise Faustman, director of the Immunobiology Laboratory at MGH who oversees the Faustman Lab, talked about discovering and developing new treatments for Type 1 diabetes to supporters.

“It’s hard to develop a generic drug development program and that wouldn’t be possible without the generosity and funding of Type One,” said Faustman. “We’ve identified a drug, BCG (developed for TB in France 125 years ago) and are in advanced human clinical trials now – Phase 2 trials – and will start a subset of clinical trials in children soon. We sincerely appreciate the philanthropy and thank Type One, their sponsors and everyone for their efforts and donations.”